Planned maintenance
A system upgrade is planned for 24/9-2024, at 12:00-14:00. During this time DiVA will be unavailable.
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Will target company's shareholders experience abnormal returns in the short-run due to an announcement of a M&A?
University West, School of Business, Economics and IT, Divison of Law, Economics, Statistics and Politics.
University West, School of Business, Economics and IT, Divison of Law, Economics, Statistics and Politics.
2021 (English)Independent thesis Advanced level (degree of Master (One Year)), 10 credits / 15 HE creditsStudent thesis
Abstract [en]

How will shareholders of a target company react to a M&A? In this study, the aim was to analyze the impact of an announcement of a merger or an acquisition in the pharmaceutical sector. This sector is special since it is high cost including research, development, and patent. Moreover, the industry has a big role when it comes to how important it is to manufacture a vaccine and bring to the market. Which is currently an important topic during the ongoing pandemic of covid-19. Mergers and acquisitions are mechanisms for companies to obtain more control and achieve success.

This report examined the short-term effect on share prices due to announcements of mergers and acquisitions during 2019-2020 of 14 companies. The method used is the market model and event study approach where abnormal returns are determined for each company for the event window (-7, +20). The results showed that all target companies achieved positive abnormal returns after the announcement day. The effect lasted the entire event period for all companies but one. The report concluded that positive abnormal returns are present in the short run for the pharmaceutical industry in 2019-2020. 

Place, publisher, year, edition, pages
2021. , p. 36
Keywords [en]
The pharmaceutical industry, Event study, Mergers and acquisitions, Shareholders, Abnormal returns
National Category
Economics
Identifiers
URN: urn:nbn:se:hv:diva-17344Local ID: EXF800OAI: oai:DiVA.org:hv-17344DiVA, id: diva2:1587102
Subject / course
Nationalekonomi
Educational program
Magister i finans
Supervisors
Examiners
Available from: 2021-08-23 Created: 2021-08-23 Last updated: 2021-08-23Bibliographically approved

Open Access in DiVA

No full text in DiVA

By organisation
Divison of Law, Economics, Statistics and Politics
Economics

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 412 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf